E735-0029 Screening compound: N-[1-(4-butoxyphenyl)ethyl]-3-({[1,2,3,4]tetrazolo[1,5-a]quinoxalin-4-yl}amino)benzamide

E735-0029 Screening compound: N-[1-(4-butoxyphenyl)ethyl]-3-({[1,2,3,4]tetrazolo[1,5-a]quinoxalin-4-yl}amino)benzamide
E735-0029 Screening compound: N-[1-(4-butoxyphenyl)ethyl]-3-({[1,2,3,4]tetrazolo[1,5-a]quinoxalin-4-yl}amino)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E735-0029
N-[1-(4-butoxyphenyl)ethyl]-3-({[1,2,3,4]tetrazolo[1,5-a]quinoxalin-4-yl}amino)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E735-0029

Molecular Formula

C27H27N7O2 (C27 H27 N7 O2)

Compound Name

N-[1-(4-butoxyphenyl)ethyl]-3-({[1,2,3,4]tetrazolo[1,5-a]quinoxalin-4-yl}amino)benzamide

IUPAC name

N-[1-(4-butoxyphenyl)ethyl]-3-({[1234]tetrazolo[15-a]quinoxalin-4-yl}amino)benzamide

SMILES

CCCCOc1ccc(C(C)NC(c2cc(Nc3nc(cccc4)c4n4nnnc34)ccc2)=O)cc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.249

Distribution Coefficient, logD

5.248

Water Solubility, LogSw

-4.92

Polar Surface Area

85.371

Acid Dissociation Constant (pKa)

12.85

Base Dissociation Constant (pKb)

4.71

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

22.20

E735-0029 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Glucocorticoid receptors Library (4806 compounds)

Lipid Metabolism Library (9174 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Cardiovascular
  • Metabolic
Targets:
  • Kinases
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E735-0029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E735-0029?
Check Price and Availability of E735-0029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E735-0029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E735-0029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E735-0029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E735-0029 available by request